Trial Profile
Long-Term Use of Inhaled Sodium Pyruvate for the Treatment of Chronic Obstructive Pulmonary Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Mar 2021
Price :
$35
*
At a glance
- Drugs Sodium pyruvate (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Emphycorp
- 05 Jan 2016 New trial record